Introduction: While it is suggested that platelet hyperreactivity plays a role in the
| INTRODUC TI ON
The development of venous thromboembolism (VTE) after total knee arthroplasty (TKA) is a severe complication, and deep venous thrombosis (DVT) is found more frequently than pulmonary embolism (PE). The use of pharmacologic prophylaxis combined with mechanical prophylaxis is recommended by the clinical guidelines of the American Academy of Orthopaedic Surgeons (AAOS) clinical guidelines.
1 However, the routine use of pharmacologic prophylaxis in Asian patients is still controversial because of an increased risk of bleeding due to pharmacologic agents and variable incidences of VTE, ranging from 1.8% to 35.7%, when mechanical prophylaxis alone was used. [2] [3] [4] [5] Previous history of VTE is a known indication for more potent anticoagulants, but other risk factors that require pharmacologic prophylaxis after TKA are not clearly defined in the Asian population. 6 Hemostasis and inflammation are linked; therefore, surgical trauma-related perioperative inflammatory state increases blood coagulability. 7 Platelet activity is one of the important components for blood coagulability because platelets are essential for hemostasis. One study reported that platelet activity and its interaction with leukocytes and endothelial cells are enhanced in patients undergoing TKA. 8 Another study indicated that spontaneous aggregation reflecting platelet activity decreases during the intraoperative period and then increases postoperatively in orthopedic surgery. 9 To date to the best of our knowledge, there have been no studies to demonstrate that platelet activity is related to postoperative VTE development.
It is well established that platelet activity plays a key role in arterial occlusive diseases, such as myocardial infarction and stroke. 10, 11 On the contrary, the relationship of VTE with platelet activity is de- This study aimed to describe whether platelet aggregation using low concentrations of agonists could classify platelet activity, and whether platelet hyperreactivity could affect the development of postoperative VTE in an elderly population that did not receive pharmacologic prophylaxis. Moreover, we analyzed that platelet phenotype is related to blood cell parameters, postoperative transfusion requirement, and perioperative inflammatory response.
| MATERIAL S AND ME THODS

| Study population
We selected 150 patients aged ≥60 years (71. 
| Laboratory tests
On the day of surgery, complete blood counts and coagulation assays, 
| Light transmission aggregometry
Prior to surgery, whole blood specimens were drawn into a sodium citrate (3.2%) containing tube, and platelet-rich plasma (PRP) was prepared by centrifugation at 200 g for 10 minutes. Autologous platelet-poor plasma (PPP) was prepared by recentrifugation at 1800 g for 15 minutes. The platelet count was adjusted to between 200 × 10³/μL and 300 × 10³/μL with autologous PPP.
Platelet aggregation was performed on a Chrono-log 700 aggregometer (Chrono-log Corp., Havertown, PA, USA). PRP was transferred into a cuvette incubated at 37°C for 3 minutes, and was stimulated by ADP or epinephrine. The aggregation pattern was allowed to generate for 10 minutes after the addition of ADP and epinephrine, and aggregation assays were performed in duplicate. The average of maximal aggregation (%) was recorded. All aggregation tests were completed within 4 hours from sample collection. First, we tested platelet aggregation at a concentration of 10 μmol/L for ADP and epinephrine, routinely used in platelet function testing, and checked that the aggregation showed the normal value of >60%. Subsequently, we measured platelet aggregation using low concentrations of agonists (1.0 μmol/L of ADP, and 0.4, 1.0 μmol/L of epinephrine) as previously reported. 16 To assess the reproducibility of the aggregation response, platelet aggregation at 0.4 μmol/L of epinephrine was measured after 1 year in 20 patients who did not have factors affecting platelet function.
| Statistical analysis
All statistical analyses were performed using MedCalc version 14.12.0 (MedCalc software, Mariakerke, Belgium). Independent t test was used for comparison of continuous variables, and the chisquare test or Fisher's exact test was used for categorical variables.
Receiver operating characteristics (ROC) curve analysis determined the optimal cutoff of maximal aggregation to predict the development of VTE. A P value <0.05 was considered statistically significant.
| RE SULTS
| Platelet aggregation induced by the low concentrations of epinephrine and ADP
In response to the low concentrations of agonists, a bimodal distribution of platelet aggregation was observed ( Figure 1 ). We classified the level of maximal aggregation into 3 groups (low, moderate, and high) according to the previous criteria. 16 At epinephrine con- We performed the follow-up platelet aggregation assay at a concentration of 0.4 μmol/L epinephrine in 20 patients (12 with <40% and 8 with ≥40% of aggregation response), and the classification group of aggregation level for each patient was sustained.
| Preoperative characteristics and epinephrine (0.4 μmol/L)-induced platelet aggregation
Demographic and preoperative laboratory characteristics of the 3 groups classified by the maximal aggregation under the stimulation of 0.4 μmol/L epinephrine are summarized in Table 1 . The degree of platelet aggregation was not affected by age, female sex, and BMI. The prevalence of hypertension showed no difference among groups. In the low aggregation group, the incidence of previous CAD and IS was lower compared to the other groups, but the difference was not significant. (Table 1 ).
| Postoperative hemostasis and epinephrine (0.4 μmol/L)-induced platelet aggregation
The Hb on postoperative days 2 and 4 did not show a significant difference among the 3 groups. However, the degree of Hb decrease on postoperative day 2, calculated RBC loss, and RBC transfusion requirement were smaller in the high aggregation group than in the low aggregation group (P = 0.012, P = 0.029, P = 0.035). On postoperative days 3 and 7, the CRP levels were not different among the 3 groups. The duration of hospitalization did not show any difference among the groups. During the 90-day follow-up period, we observed a total of 11 VTE events (7.3%), which were all DVT, and there was TA B L E 1 Demographic and preoperative laboratory characteristics in the groups classified by basal platelet aggregation at 0.4 μmol/L epinephrine no PE event. The frequency of VTE was significantly higher in the group with an aggregation of 40% or more (P < 0.0001) ( Table 2 ).
The detected sites of DVT were the soleal vein (8 patients 
| Development of DVT and heightened aggregation at the low concentrations of agonists
The incidence of maximal aggregation >40% under the low concentrations of ADP and epinephrine was significantly higher in patients with DVT, whereas the risk factors such as female sex, advanced age (>70 years), obesity (BMI ≥30), and presence of hypertension were not associated with the presence of DVT. When maximal aggregation >40% was applied as a cutoff value to predict the development of DVT, sensitivity of each aggregation test 
| D ISCUSS I ON
The heightened platelet activity, so called hyperreactivity, indicates enhanced responses to low concentrations of agonists in aggregometry. It has been reported that platelet aggregation at the low concentrations of agonists varies between individuals in a healthy population, and the subjects who exhibit hyperreactivity to
one agonist tend to demonstrate a similar response to other agonists. 16 We determined the pattern of platelet aggregation using the In western healthy controls, few subjects demonstrated moderate aggregation at low concentrations of all agonists, and >60% aggregation represented a criterion of platelet hyperreactivity. 16 In our population, 11.3%-15.3% belonged to moderate aggregation group at each agonist condition, and some subjects showing moderate aggregation at 0.4 μmol/L epinephrine exhibited high aggregation at 1.0 μmol/L of epinephrine or ADP. We proposed that aggregation <40% may be considered as the criterion to classify subjects with low platelet aggregation, but the criterion to define platelet hyperreactivity needs to be adjusted according to the agonist and its concentration.
When we presented 40% of the aggregation as the cutoff to predict the development of postoperative DVT, all agonist conditions showed the same high sensitivity (90.9%). However, specificity values were low from 55.4% to 74.1%, even though the specificity of 0.4 μmol/L epinephrine was higher than that of other agonist conditions. The aggregation response at 0.4 μmol/L epinephrine was proposed to be competent in assessing platelet activity, 16 so we assumed that a platelet aggregation assay at 0.4 μmol/L epinephrine would allow the differentiation of platelet phenotype, and enhanced platelet aggregation or platelet hyperreactivity may be a risk factor for postoperative VTE.
Advanced age >70 years, female sex, obesity, and hypertension have been known as risk factors of VTE after TKA. 6, 15 In this study, platelet aggregation ≥40% was more frequently observed in patients with VTE, while the incidences of these risk factors were not significantly higher. The relation between the known risk factors and VTE could not be proved because most patients in our population had at least one of the known risk factors. Our data show that enhanced platelet aggregation might promote the development of postoperative VTE, irrespective of the known risk factors.
Prior clinical studies observed that WBC and platelet counts are correlated with increased platelet aggregation in arterial thrombotic events. 19, 20 In the present study, the incidence of previous arterial thrombotic events such as CAD and IS, WBC count, and platelet count showed no significant difference among the aggregation groups, although it was lower in the low aggregation group. WBC and platelet counts were not correlated with the degree of aggregation at 0.4 μmol/L epinephrine. Instead, MPV was significantly lower in the low aggregation group than in the high aggregation group. These results indicated that larger platelets were more active than the normal-sized platelets, and WBC and platelet counts within the normal range have a limited effect on platelet aggregation. Moreover, we speculated that the history of arterial thrombotic events was not linked with the possibility of platelet hyperreactivity.
The relation between thrombosis and WBC or platelet counts is not definitive. On the contrary, some studies have shown that the MPV is higher in myocardial infarction and is associated with increased VTE risk. [21] [22] [23] [24] The number of DVT events in the present study was small, and there was no difference in WBC or platelet counts; however, MPV was different between patients with DVT and those without DVT. These findings validate that the size of platelets was indirectly related to the development of venous thrombosis through platelet activity.
Postoperative VTE in arthroplasty of the lower extremities remains as a severe complication. Because TKA is widely performed in the elderly populations, it is important to determine the combined use of pharmacological and mechanical prophylaxis.
3 Until now, a few studies have evaluated platelet hyperreactivity in venous thrombosis; however, its role in postoperative VTE has not been established. [12] [13] [14] 25 In the present study, we showed that heightened platelet activity was associated with postoperative VTE in elderly patients without major risk factors. Therefore, platelet aggregation at 0.4 μmol/L epinephrine might help clinicians to select the prophylactic strategy. Further, platelet phenotype-based case-control studies investigating platelet activity are warranted.
Perioperative decline in platelet function has been reported to correlate with perioperative blood loss and transfusion rate in coronary surgery. 26 Indeed, platelets are one of the coordinators of inflammation. 27 We evaluated whether basal platelet phenotype impacted postoperative blood loss, transfusion requirement, and perioperative inflammatory response. The degree of postoperative Hb decrease, calculated volume of RBC loss, and transfused RBC units were smaller in patients with high aggregation (>60%), but CRP level after surgery was not related to platelet aggregation.
Hence, we speculate that platelet phenotype has an effect on postoperative hemostasis, but not on perioperative inflammatory response.
In conclusion, aggregation response to 0.4 μmol/L epinephrine is an optimal assay to classify platelet activity. Platelet activity is related to MPV and postoperative hemostasis. Platelet hyperreactivity may increase the risk of postoperative VTE by increasing blood coagulability, and could be an indication of pharmacologic prophylaxis.
O RCI D
Jimyung Kim http://orcid.org/0000-0003-0530-3425
